Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
Clinical trial NCT04862260 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04862260
- Sponsor
- CHU de Quebec-Universite Laval
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-04
- Primary completion
- 2025-01-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.